http://articles.mercola.com/sites/articles/archive/2000/03/12/fda-recommends-bp-drug-stop.aspxThe National Heart, Lung, and Blood Institute (NHLBI) halted at least one part of a large study of the blood pressure drug doxazosin because patients on the drug did not do as well as those on an alternate medication. Patients taking the drug, also knownenCommunityServer 2008.5 SP1 (Build: 31106.3070)